Greenwich LifeSciences Inc. (GLSI) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Greenwich LifeSciences In...

    NASDAQ: GLSI · Real-Time Price · USD
    10.93
    -0.04 (-0.36%)
    At close: Sep 05, 2025, 3:59 PM
    10.81
    -1.10%
    After-hours: Sep 05, 2025, 05:17 PM EDT

    Greenwich LifeSciences Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 3.61K 3.61K 3.61K 3.61K
    Gross Profit
    		 -3.61K -3.61K -3.61K -3.61K
    Operating Income
    		 -16.01M -9.33M -8.04M -4.6M
    Interest Income
    		 223.01K 436.06K 215.02K 27.37K
    Pretax Income
    		 -15.79M -8.89M -7.83M -4.57M
    Net Income
    		 -15.79M -8.89M -7.83M -4.57M
    Selling & General & Admin
    		 3.06M 1.63M 1.56M 1.04M
    Research & Development
    		 12.95M 7.7M 6.48M 3.56M
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 16.01M 9.33M 8.04M 4.6M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 16.01M 9.33M 8.04M 4.6M
    Income Tax Expense
    		 n/a n/a -215.02K -27.37K
    Shares Outstanding (Basic)
    		 13.01M 12.85M 12.91M 12.94M
    Shares Outstanding (Diluted)
    		 13.01M 12.85M 12.91M 12.94M
    EPS (Basic)
    		 -1.21 -0.69 -0.61 -0.35
    EPS (Diluted)
    		 -1.21 -0.69 -0.61 -0.35
    EBITDA
    		 -15.79M -9.32M -8.04M -4.59M
    EBIT
    		 -15.79M -9.33M -8.04M -4.6M
    Depreciation & Amortization
    		 3.61K 3.61K 3.61K 3.61K

    Add to Watchlist